Vivos Therapeutics, Inc. Stock
Equities
VVOS
US92859E2072
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | -1.41% | -10.02% | -83.44% |
May. 14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 14.9M | Sales 2025 * | 18.41M | Capitalization | 6.23M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -10M | EV / Sales 2024 * | 0.42 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-0.5
x | P/E ratio 2025 * |
-0.92
x | Employees | 119 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.75% |
Latest transcript on Vivos Therapeutics, Inc.
1 day | -1.88% | ||
1 week | -7.52% | ||
Current month | -17.39% | ||
1 month | -21.13% | ||
3 months | -57.35% | ||
6 months | -47.62% | ||
Current year | -83.20% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Huntsman
FOU | Founder | - | 16-07-06 |
RaeAnn Byrnes
FOU | Founder | - | 16-07-06 |
Susan McCullough
FOU | Founder | - | 16-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Sokolow
BRD | Director/Board Member | 67 | 20-05-31 |
Mark Lindsay
BRD | Director/Board Member | 61 | 20-05-31 |
Anja Krammer
BRD | Director/Board Member | 56 | 20-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.06 | -1.41% | 1 477 |
24-05-23 | 2.09 | -1.88% | 21,400 |
24-05-22 | 2.13 | -3.18% | 32,800 |
24-05-21 | 2.2 | -1.79% | 25,144 |
24-05-20 | 2.24 | -2.18% | 26,828 |
Delayed Quote Nasdaq, May 23, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.20% | 6.23M | |
+75.33% | 12.54B | |
-24.19% | 7.39B | |
+6.43% | 6.62B | |
+13.59% | 5.43B | |
+34.82% | 4.81B | |
-14.56% | 4.8B | |
-25.57% | 3.72B | |
-26.93% | 2.76B | |
+49.43% | 2.4B |
- Stock Market
- Equities
- VVOS Stock